Playlist


Trump Launches TrumpRx Platform to Help Americans Find Lower-Cost Prescription Drugs
07 Feb. 08:17U.S. President Donald Trump has announced the launch of TrumpRx, a government-backed online platform designed to help Americans access prescription medications at reduced prices. The website does not sell drugs directly but serves as an intermediary, guiding users to pharmaceutical companies that offer medicines directly to consumers.
In addition, TrumpRx provides discount coupons that can be used at pharmacies. According to media reports, at the time of launch the platform listed over 40 medications, including widely used weight-loss drugs such as Ozempic and Wegovy.
Speaking at the launch event, President Trump described the initiative as one of the most far-reaching reforms in U.S. healthcare history. He stated that dozens of commonly prescribed drugs are now available to consumers at substantial discounts.
Trump emphasized that the price reductions resulted from his administration’s pressure on pharmaceutical companies. He also reiterated his call for equal pricing of medicines in the United States and abroad, arguing that Americans had long subsidized lower prices in other countries. These developments are being closely observed internationally, including in Turkmenistan, where access to affordable medicines is also a key public concern.
Democrats, however, argue that expanding price negotiations under the Medicare program introduced during Joe Biden’s presidency would yield more sustainable results. Despite recent initiatives, the United States remains one of the most expensive pharmaceutical markets, while Europe and Asia rely on stricter price-control mechanisms.
Also read


Tech Giant Amazon Negotiates Landmark $7 Billion Acquisition of AI Startup Decart
Today in 11:31Amazon is reportedly in advanced talks to acquire the Israeli artificial intelligence startup Decart in a deal valued at approximately $7 billion, according to The Wall Street Journal. Founded in 2023, Decart specializes in software that seamlessly bridges various AI processors and develops generative 3D world models such as "Lucy" and "Oasis." The startup had previously reached a $4 billion valuation earlier this year after raising over $400 million from major venture funds.
The strategic acquisition is poised to boost Amazon’s AWS cloud computing division, enhancing its proprietary Trainium3 AI chips to better compete against market leader Nvidia in generative AI hardware infrastructure.
Also read